Skip to content

Assessing the suture condition with the application of fluorescence-emitting sutures

The clinical application of fluorescence-emitting medical device

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033430
Enrollment
Unknown
Registered
2020-05-31
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The acoustic neuroma patients receiving operation via retrosigmoid approch

Interventions

Gold Standard:The numbers of sutures or knots would be calculated intraoperatively by neurosurgeons
Index test:The&#32
numbers&#32
of&#32
sutures&#32
or&#32
knots&#32
in&#32
layers&#32
displayed&#32
imaging&#32
be&#32
assessed.&#32
The&#32

Sponsors

Beijing Tiantan Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years old; 2. Acoustic neuroma patients to be treated by retrosigmoid approach; 3. Patients who can sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with recurrent tumors who have undergone tumor resection; 2. Patients with local skin damage caused by other reasons; 3. Patients who refused to participate in the study.

Design outcomes

Primary

MeasureTime frame
The numbers of sutures or knots indicated by fluorescence;

Secondary

MeasureTime frame
The fluorescence intensities relavant to the depth of sutures or knots underneath skin;The fluorescence intensity change 30 days postoperatively duet to the suture absorption;

Countries

China

Contacts

Public ContactWang Jia

Beijing Tiantan Hospital Affiliated to Capital Medical University

jwttyy@126.com+86 10-59976512

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026